Title:
COMPOUND FOR REDUCING URIC ACID
Document Type and Number:
WIPO Patent Application WO/2023/208108
Kind Code:
A1
Abstract:
Disclosed herein is a compound for reducing uric acid, which is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. The present invention can significantly reduce the serum uric acid level in a rat hyperuricemia model, and has potential application value in aspects of anti-gout therapies, anti-hyperuricemia therapies, and the like.
Inventors:
SHI DONGFANG (CN)
FU ZHANGJIN (CN)
YANG YAN (CN)
LI HAIMING (CN)
YUAN CHENGYI (CN)
FU ZHANGJIN (CN)
YANG YAN (CN)
LI HAIMING (CN)
YUAN CHENGYI (CN)
Application Number:
PCT/CN2023/091140
Publication Date:
November 02, 2023
Filing Date:
April 27, 2023
Export Citation:
Assignee:
JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD (CN)
International Classes:
C07D275/04; A61K31/4155; A61K31/416; A61K31/4192; A61K31/4439; A61P19/06; C07D401/04; C07D403/04; C07D405/04; C07D405/14; C07D409/04
Domestic Patent References:
| WO2010093191A2 | 2010-08-19 |
Foreign References:
| CN115160299A | 2022-10-11 | |||
| EP2338887A1 | 2011-06-29 | |||
| CN101282936A | 2008-10-08 | |||
| US20140005221A1 | 2014-01-02 | |||
| CN105439946A | 2016-03-30 | |||
| CN102574839A | 2012-07-11 | |||
| CN103459381A | 2013-12-18 | |||
| CN107759588A | 2018-03-06 | |||
| CN106432229A | 2017-02-22 |
Attorney, Agent or Firm:
NANJING SITUO INTELLECTUAL PROPERTY AGENCY (GP) (CN)
Download PDF: